Brewin Dolphin Wealth Management LTD Charles River Laboratories International, Inc. Transaction History
Brewin Dolphin Wealth Management LTD
- $917 Million
- Q2 2022
A detailed history of Brewin Dolphin Wealth Management LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Brewin Dolphin Wealth Management LTD holds 65 shares of CRL stock, worth $10,853. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65
Previous 65
-0.0%
Holding current value
$10,853
Previous $18,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
709Shares Held
49.8MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.03 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$850 Million0.02% of portfolio
-
State Street Corp Boston, MA2.18MShares$364 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$302 Million0.56% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.81MShares$301 Million0.79% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.49B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...